Therapeutic Goods (Biologicals—Authorised Supply) Rules 2022

Therapeutic Goods (Biologicals—Authorised Supply) Rules 2022

made under subsection 32CM(7A) of the

Therapeutic Goods Act 1989

Compilation No. 5

Compilation date: 7 November 2025

Includes amendments: F2025L00947

About this compilation

This compilation

This is a compilation of the Therapeutic Goods (Biologicals—Authorised Supply) Rules 2022 that shows the text of the law as amended and in force on 7 November 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).

Application, saving and transitional provisions

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

1  Name

3  Authority

4  Definitions

5  Authorisation

Schedule 1—Biologicals authorised for supply

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

1  Name

  This instrument is the Therapeutic Goods (Biologicals—Authorised Supply) Rules 2022.

3  Authority

  This instrument is made under subsection 32CM(7A) of the Therapeutic Goods Act 1989.

4  Definitions

Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:

(a) biological;

(b) health practitioner;

(c) included in the Register;

(d) Register;

(e) sponsor;

(f) supply.

  In this instrument:

Act means the Therapeutic Goods Act 1989.

adverse event means an adverse event that occurs in relation to a person in Australia following the administration of a biological.

Note: An adverse event may not necessarily have a causal relationship with the administration or use of the biological.

Therapeutic Goods Administration has the same meaning as in the Therapeutic Goods Regulations 1990.

5  Authorisation

Supply by a specified health practitioner

 (1) A health practitioner specified in column 5 of an item in the table in Schedule 1 is authorised to supply a biological to a patient of that practitioner where:

 (a) the biological is specified in column 2 of that item; and

 (b) the biological is to be administered by the route specified in column 3 of that item; and

 (c) the supply is for the indication specified in column 4 of that item; and

 (d) the conditions specified in subsection (2) are satisfied.

 (2) The health practitioner must:

 (a) inform the patient, or a parent or guardian of the patient, that the biological is not included in the Register; and

 (b) obtain informed consent from the patient, or a parent or guardian of the patient, in relation to, and before, the supply of the biological; and

 (c) supply the biological in accordance with good medical practice or the relevant code of conduct for the health practitioner; and

 (d) if the health practitioner becomes aware that the patient has suffered an adverse event in relation to the biological—notify the Therapeutic Goods Administration within 15 days of becoming aware of the adverse event; and

 (e) if the health practitioner becomes aware of a defect in the biological—notify the Therapeutic Goods Administration within 15 days of becoming aware of the defect.

Supply to a patient of a specified health practitioner

 (3) A health practitioner is authorised to supply a biological to a patient of a health practitioner specified in column 5 of an item in the table in Schedule 1 (the treating practitioner) where:

 (a) the biological is specified in column 2 of that item; and

 (b) the supply is requested by the treating practitioner; and

 (c) the biological is to be administered by the route specified in column 3 of that item; and

 (d) the supply is for the indication specified in column 4 of that item; and

 (e) the conditions specified in subsection (4) are satisfied.

 (4) The health practitioner supplying the biological must:

 (a) if the health practitioner becomes aware that the patient has suffered an adverse event in relation to the biological—notify the Therapeutic Goods Administration within 15 days of becoming aware of the adverse event; and

 (b) if the health practitioner becomes aware of a defect in the biological—notify the Therapeutic Goods Administration within 15 days of becoming aware of the defect.

Schedule 1—Biologicals authorised for supply

Note: See section 5.

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history